← FDA Drug Approvals (Drugs@FDA)

IHEEZO

NDA · New Drug Application · Sponsor: HARROW EYE · Approved 2022-09-27

Drug application

FDA Application #

NDA216227

Application type

New Drug Application

Brand name

IHEEZO

Generic name

CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL

Active ingredients

CHLOROPROCAINE HYDROCHLORIDE

Dosage form

GEL

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

HARROW EYE

Manufacturer

Harrow Eye, LLC

First approval

2022-09-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown